Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-10-011112
Filing Date
2010-03-03
Accepted
2010-03-03 08:00:34
Documents
8
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 v176034_10k.htm 10-K 1931195
2 v176034_ex10-14.htm EX-10.14 100164
3 v176034_ex23-1.htm EX-23.1 4087
4 v176034_ex23-2.htm EX-23.2 3849
5 v176034_ex31-1.htm EX-31.1 10399
6 v176034_ex31-2.htm EX-31.2 10340
7 v176034_ex32-1.htm EX-32.1 6022
8 v176034_ex32-2.htm EX-32.2 6022
  Complete submission text file 0001144204-10-011112.txt   2073598
Mailing Address 4 WEST 4TH AVE SUITE 400 SAN MATEO CA 94402
Business Address 4 WEST 4TH AVE SUITE 400 SAN MATEO CA 94402 (415) 875-7880
Nile Therapeutics, Inc. (Filer) CIK: 0001133869 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-34058 | Film No.: 10651519
SIC: 2834 Pharmaceutical Preparations